Pharma news

Reset all filters
Geography
Company
Refine search
Indian court dismisses Teva’s bid to block Copaxone generic
Asia
The Delhi High Court has dismissed Teva’s action to stop Hyderabad-based Natco Pharma from marketing a generic version of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).   3 March 2014
Beyond patent enforcement: the Herceptin phoenix
Asia
While Western pharmaceutical companies struggle to enforce their IP rights in India, Roche has taken an unorthodox but surprisingly effective stance, as Debashish Banerjee and Shukadev Khuraijam explain.   28 February 2014
Bayer to buy traditional Chinese medicine group
Asia
Bayer has announced that it plans to acquire Dihon Pharmaceutical Group, a Chinese company that makes over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products.   27 February 2014
Americas
Actavis has announced another expansion with the $25 billion acquisition of US pharmaceutical company Forest Laboratories.   21 February 2014
Pharma
Several of the world’s 10 top-selling drugs lose exclusivity this year. LSIPR takes a look at the products, their major competitors, and their manufacturers’ strategies for keeping a grasp of market share.   19 February 2014
Pharma
The CJEU has delivered its judgment in three SPC cases, in an attempt to address fundamental issues in the SPC Regulation, as well as uncertainties arising from earlier rulings. Although questions have been answered, others have been raised, say David Carling and Michael Pears.   19 February 2014
Asia
The Indian Supreme Court has failed to provide the clarity which is craved by practitioners in its latest pronouncement on the controversial Section 3(d), says Jitesh Kumar.   19 February 2014
Pharma
Common themes, in particular in the context of second medical use claims and dosage regimes, are on the radar of the UK courts, as Jennifer Antcliff and Dennis Waller report.   19 February 2014
Asia-Pacific
Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies.   18 February 2014
Americas
Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum.   18 February 2014